Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of LCZ696 and Sildenafil in Hypertension
NCT01601470Phase 2Completed
- Sponsor
- Novartis
- Start
- Sep 2012
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sacubitril + valsartan in hypertension (HTN), sponsored by Novartis. Primary endpoints: Area Under the Plasma Concentration-time Curve From Time Zero to the End of the Dosing Interval at Day 8, Maximum Plasma Concentration Following Drug Administration at Steady State at Day 8 and 6 more. Started Sep 2012; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01601470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01601470.